SCHEMBL25001905

SCHEMBL25001905

COc1cc(N2CCOCC2)c(-c2cnn(C)c2)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2N(C)[S+](C)[O-])n1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.53
▸ BTK Q06187 1/20 0.53
▸ TTK P33981 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25001403 0.89 EGFR (0.59) EGFRBTKTTK
SCHEMBL25001890 0.86 EGFR (0.55) EGFRBTKTTK
SCHEMBL22950947 0.86 EGFR (0.64) EGFRBTK
SCHEMBL25002442 0.85 EGFR (0.54) EGFRBTKTTK
SCHEMBL30741317 0.84 EGFR (0.65) EGFRBTKTTK
SCHEMBL25001544 0.84 EGFR (0.65) EGFRBTKTTK
SCHEMBL25002757 0.84 EGFR (0.48) EGFRBTKTTK
SCHEMBL25820802 0.83 EGFR (0.58) EGFRBTKTTK
SCHEMBL25001345 0.82 EGFR (0.61) EGFRBTK
SCHEMBL25002032 0.82 EGFR (0.48) EGFRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback